Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on: November 08,2024 0

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on:November 08,2024 0

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on: April 01,2024 13

Stopping cancer from recruiting immune system double agents

by Rush University Medical CenterCredit: Rush University Medical CenterCancerous tumors trick myeloid cells, an important part of the immune system, into perceiving them as a damaged part of the

Updated on:April 01,2024 13

Seeking microscopic clues to beating deadly brain tumors

by Hackensack Meridian HealthH&E stained sections of patient glioblastoma samples. Higher magnifcation of representative regions are shown in the colored boxes. Histologic features include low (bl

Updated on: January 23,2024 17

Seeking microscopic clues to beating deadly brain tumors

by Hackensack Meridian HealthH&E stained sections of patient glioblastoma samples. Higher magnifcation of representative regions are shown in the colored boxes. Histologic features include low (bl

Updated on:January 23,2024 17

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on: January 29,2024 12

In situ, invasive melanoma diagnoses decreased in 2020

by Elana GotkineDuring 2020, there were decreases seen for in situ and invasive melanoma diagnoses, according to a research letter published online Sept. 6 inJAMA Dermatology.Daniel Y. Kim, from

Updated on:January 29,2024 12

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing

Updated on: January 16,2024 18

Study: Access to cannabis for cancer patients is not equitable

by Bert Gambini,University at BuffaloCredit: Pixabay/CC0 Public DomainThe same factors driving many health care disparities in the U.S. are also affecting who has access to cannabis for managing

Updated on:January 16,2024 18

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April

Updated on: April 06,2024 0

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April

Updated on:April 06,2024 0

Breast MRI illuminates risk of second breast cancer

byRadiological Society of North AmericaPostoperative surveillance images in a 54-year-old woman who had undergone right breast–conserving surgery and postoperative radiation therapy 2 years prio

Updated on: January 02,2024 9

Breast MRI illuminates risk of second breast cancer

byRadiological Society of North AmericaPostoperative surveillance images in a 54-year-old woman who had undergone right breast–conserving surgery and postoperative radiation therapy 2 years prio

Updated on:January 02,2024 9

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on: January 22,2024 17

Study examines hesitation toward potential changes to bowel cancer surveillance

byFlinders UniversityCredit: Pixabay/CC0 Public DomainAs doctors and researchers discuss whether to push recommended bowel cancer colonoscopy surveillance intervals out beyond five years, new re

Updated on:January 22,2024 17

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on: January 12,2024 15

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on:January 12,2024 15

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on: February 23,2024 20

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on:February 23,2024 20

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on: February 18,2024 14

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on:February 18,2024 14

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on: April 14,2024 15

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on:April 14,2024 15